Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Szumny, Dorota ^a,b   Sozański, Tomasz ^a   Kucharska, Alicja Z ^c   Dziewiszek, Wojciech ^a   Piórecki, Narcyz ^d,e   Magdalan, Jan ^a   Chlebda Sieragowska, Ewa ^a   Kupczynski, Robert ^c   Szeląg, Adam ^a   Szumny, Antoni ^c  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu   (Poland)

^c WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^d Arboretum and Institute of Physiography in Bolestraszyce   (Poland)

^e UNIVERSITY OF RZESZÓW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

5 O CAFFEOYLQUINIC ACID; ANTHOCYANIN; ANTIGLAUCOMA AGENT; CHLOROGENIC ACID; CORNUS MAS EXTRACT; CORNUSIDE; CYANIDIN 3 O GALACTOSIDE; CYANIDIN 3 O ROBINOBIOSIDE; DELPHINIDIN 3 O GALACTOSIDE; FLAVONOL DERIVATIVE; IRIDOID; KAEMPFEROL 3 GALACTOSIDE; LOGANIC ACID; PELARGONIDIN 3 GALACTOSIDE; PELARGONIDIN 3 O GALACTOSIDE; PELARGONIDIN 3 O ROBINOBIOSIDE; PLACEBO; PLANT EXTRACT; POLYPHENOL DERIVATIVE; QUERCETIN 3 O GLUCURONIDE; TIMOLOL MALEATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CORNUS; CORNUS MAS; DRUG ADMINISTRATION ROUTE; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; EYE BLOOD FLOW; FEMALE; GLAUCOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRACONJUNCTIVAL DRUG ADMINISTRATION; INTRAOCULAR PRESSURE; IRIS BLOOD VESSEL; MALE; NEW ZEALAND RABBIT; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84934950281     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/939402     Document Type: Article

References (51)

1. D. Ackland, N. Kumaran, and R. Zia, "Treating glaucoma: the not-so-nice guidance", British Journal of Ophthalmology, vol. 98, no. 9, pp. 1139-1140, 2013.
2. I. I. Bussel and A. A. Aref, "Dietary factors and the risk of glaucoma: a review", Therapeutic Advances in Chronic Disease, vol. 5, no. 4, pp. 188-194, 2014.
3. D. Peters, B. Bengtsson, and A. Heijl, "Factors associated with lifetime risk of open-angle glaucoma blindness", Acta Ophthalmologica, vol. 92, no. 5439, pp. 421-425, 2014.
4. M. E. Cavet, J. L. Vittitow, F. Impagnatiello, E. Ongini, and E. Bastia, "Nitric oxide (NO): an emerging target for the treatment of glaucoma", Investigative Ophthalmology & Visual Science, vol. 55, no. 8, pp. 5005-5015, 2014.
5. D. J. Rhee, "Preventing glaucoma in a high-risk population: impact and observations of the ocular hypertension treatment study", Archives of Ophthalmology, vol. 127, no. 2, pp. 216-218, 2009.
6. L. J. Rosenbaum, "Management of patients with ocular hypertension: a cost-effectiveness approach from the ocular hypertension treatment study", The American Journal of Ophthalmology, vol. 143, no. 1, pp. 191-192, 2007.
7. M. Mulak, D. Szumny, A. Sieja-Bujewska, and M. Kubrak, "Heidelberg edge perimeter employment in glaucoma diagnosis: preliminary report", Advances in Clinical and Experimental Medicine, vol. 21, no. 5, pp. 665-670, 2012.
8. F. Aptel, A. Béglé, A. Razavi et al., "Short- and long-term effects on the ciliary body and the aqueous outflow pathways of highintensity focused ultrasound cyclocoagulation", Ultrasound in Medicine & Biology, vol. 40, no. 9, pp. 2096-2106, 2014.
9. R. A. Coulter, J. D. Bartlett, and R. G. Fiscella, "Pharmacotherapy of the ophthalmic patient", in ClinicalOcular Pharmacology, J. D. Bartlett and S. D. Jaanus, Eds., chapter 1, pp. 3-15, Butterworth-Heinemann, St. Louis, Mo, USA, 5th edition, 2008.
10. H. D. Jampel, "Pharmacotherapy in Glaucoma: edited by Selim Orgul and Josef Flammer, Bern, Verlag Hans Huber, 2000, 333 pages, illus", Survey of Ophthalmology, vol. 46, no. 2, p. 192, 2001.
11. T. V. Johnson and S. I. Tomarev, "Rodent models of glaucoma", Brain Research Bulletin, vol. 81, no. 2-3, pp. 349-358, 2010.
12. S. I. Tomarev, "Animal models of glaucoma", in Encyclopedia of the Eye, D. A. Dartt, Ed., pp. 106-111, Academic Press, Oxford, UK, 2010.
13. J. Caprioli and M. Sears, "Combined effect of forskolin and acetazolamide on intraocular pressure and aqueous flow in rabbit eyes", Experimental Eye Research, vol. 39, no. 1, pp. 47-50, 1984.
14. V. Gunasekera, E. Ernst, and D. G. Ezra, "Systematic Internetbased review of complementary and alternative medicine for glaucoma", Ophthalmology, vol. 115, no. 3, pp. 435.e2-439.e2, 2008.
15. H. T. Balaydn, M. Şentürk, S. Göksu, and A. Menzek, "Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols and their derivatives including natural products: Vidalol B", European Journal of Medicinal Chemistry, vol. 54, pp. 423-428, 2012.
16. J. C. Merritt, W. J. Crawford, P. C. Alexander, A. L. Anduze, and S. S. Gelbart, "Effect of marihuana on intraocular and blood pressure in glaucoma", Ophthalmology, vol. 87, no. 3, pp. 222-228, 1980.
17. S. Pinar-Sueiro, R. Rodríguez-Puertas, and E. Vecino, "Cannabinoid applications in glaucoma", Archivos de la Sociedad Espanola de Of talmologia, vol. 86, no. 1, pp. 16-23, 2011.
18. P. Trittibach, B. E. Frueh, and D. Goldblum, "Bilateral angleclosure glaucoma after combined consumption of 'ecstasy' and marijuana", The American Journal of Emergency Medicine, vol. 23, no. 6, pp. 813-814, 2005.
19. I. Ilieva, K. Ohgami, K. Shiratori et al., "The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo", Experimental Eye Research, vol. 79, no. 2, pp. 181-187, 2004.
20. X.-S. Mi, J.-X. Zhong, R. C.-C. Chang, and K.-F. So, "Research advances on the usage of traditional Chinese medicine for neuroprotection in glaucoma", Journal of Chinese Integrative Medicine, vol. 11, no. 4, pp. 233-240, 2013.
21. L. Quaranta, S. Bettelli, M. G. Uva, F. Semeraro, R. Turano, and E. Gandolfo, "Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma", Ophthalmology, vol. 110, no. 2, pp. 359-362, 2003.
22. S. Dorairaj, R. Ritch, and J. M. Liebmann, "Visual improvement in a patient taking Ginkgo Biloba extract: a case study", Explore: The Journal of Science and Healing, vol. 3, no. 4, pp. 391-395, 2007.
23. L. A. Dethloff, T. Chang, and C. L. Courtney, "Toxicological comparison of a muscarinic agonist given to rats by gavage or in the diet", Food and Chemical Toxicology, vol. 34, no. 4, pp. 407-422, 1996.
24. N. Z. Gharagozloo, S. J. Relf, and R. F. Brubaker, "Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145)", Ophthalmology, vol. 95, no. 9, pp. 1217-1220, 1988.
25. A. McIntyre, "The eyes", in Herbal Treatment of Children, A. McIntyre, Ed., chapter 13, pp. 285-291, Butterworth-Heinemann, Edinburgh, Scotland, 2005.
26. B.. Sarić-Kundalić, C. Dobeš, V. Klatte-Asselmeyer, and J. Saukel, "Ethnobotanical study on medicinal use of wild and cultivated plants in middle, south and west Bosnia and Herzegovina", Journal of Ethnopharmacology, vol. 131, no. 1, pp. 33-55, 2010.
27. R. Mokkapatti, "An experimental double-blind study to evaluate the use of Euphrasia in preventing conjunctivitis", British Homoeopathic Journal, vol. 81, no. 1, pp. 22-24, 1992.
28. M. Loo, "Conjunctivitis", in Integrative Medicine for Children, M. Loo, Ed., chapter 25, pp. 263-268, WB Saunders, St. Louis, Mo, USA, 2009.
29. T. Sozański, A. Kucharska, A. Szumny et al., "The protective effect of the Cornus mas fruits (cornelian cherry) on hypertriglyceridemia and atherosclerosis through PPARα activation in hypercholesterolemic rabbits", Phytomedicine, vol. 21, no. 13, pp. 1774-1784, 2014.
30. A. Z. Kucharska, A. Szumny, and J. Oszmiański, "Method of preparing of loganic acid", Polish Patent no. 388632, 2010 (Polish).
31. M. Leiva, C. Naranjo, and M. T. Peña, "Comparison of the rebound tonometer (ICare) to the applanation tonometer (Tonopen XL) in normotensive dogs", Veterinary Ophthalmology, vol. 9, no. 1, pp. 17-21, 2006.
32. S. Prabhakar, B. Mahesh, and M. Shanthamallappa, "A comparative study of intraocular pressure measurement by three tonometers in normal subjects", Nepalese Journal of Ophthalmology, vol. 5, no. 2, pp. 201-206, 2013.
33. S. Salim, H. Du, and J. Wan, "Comparison of intraocular pressure measurements and assessment of intraobserver and interobserver reproducibility with the portable icare rebound tonometer and goldmann applanation tonometer in glaucoma patients", Journal of Glaucoma, vol. 22, no. 4, pp. 325-329, 2013.
34. C. Schweier, J. V. M. Hanson, J. Funk, and M. Töteberg-Harms, "Repeatability of intraocular pressure measurements with Icare PRO rebound, Tono-Pen AVIA, and Goldmann tonometers in sitting and reclining positions", BMC Ophthalmology, vol. 13, article 44, 2013.
35. A. M. Pawlowska, F. Camangi, and A. Braca, "Quali-quantitative analysis of flavonoids of Cornusmas L. (Cornaceae) fruits", Food Chemistry, vol. 119, no. 3, pp. 1257-1261, 2010.
36. K. Chan, "The Pharmacology of Chinese Herbs; Kee Chang Huang Published 1993 CRC Press, Inc., Boca Raton, FL 388 pages; ISBN 0 8493 4915 X m100.00", Journal of Pharmacy and Pharmacology, vol. 46, no. 2, pp. 159-160, 1994.
37. W. Ma, K. J. Wang, C.-S. Cheng et al., "Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy", Journal of Ethnopharmacology, vol. 153, no. 3, pp. 840-845, 2014.
38. Edited by Øyvind M. Andersen and Kenneth R. Markham S. Quideau, "Flavonoids. Chemistry, Biochemistry and Applications. Edited by Øyvind M. Andersen and Kenneth R. Markham", Angewandte Chemie International Edition, vol. 45, no. 41, pp. 6786-6678, 2006.
39. M. Wu, P. Wu, M. Liu, H. Xie, Y. Jiang, and X. Wei, "Iridoids fromGentiana loureirii", Phytochemistry, vol. 70, no. 6, pp. 746-750, 2009.
40. X. Zhang, Q. Xu, H. Xiao, and X. Liang, "Iridoid glucosides from Strychnos nux-vomica", Phytochemistry, vol. 64, no. 8, pp. 1341-1344, 2003.
41. S. Deng, B. J. West, and C. J. Jensen, "UPLC-TOF-MS characterization and identification of bioactive iridoids in cornus mas fruit", Journal of AnalyticalMethods in Chemistry, vol. 2013, Article ID 710972, 7 pages, 2013.
42. C. Bergeron, A. Marston, R. Gauthier, and K. Hostettmann, "Iridoids and secoiridoids fromGentiana linearis", Phytochemistry, vol. 44, no. 4, pp. 633-637, 1997.
43. J. S. Kim, "Seeds of Cornus officinalis and diabetic cataracts", in Handbook of Nutrition, Diet and the Eye, V. R. Preedy, Ed., chapter 45, pp. 451-458, Academic Press, San Diego, Calif, USA, 2014.
44. W. Ma, K.-J. Wang, C.-S. Cheng et al., "Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy", Journal of Ethnopharmacology, vol. 153, no. 3, pp. 840-845, 2014.
45. W.-L. Jiang, S.-P. Zhang, J. Hou, and H.-B. Zhu, "Effect of loganin on experimental diabetic nephropathy", Phytomedicine, vol. 19, no. 3-4, pp. 217-222, 2012.
46. P.-C. Hsu, Y. Tsai, J. Lai, C. Wu, S. Lin, and C. Huang, "Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study", Journal of Ethnopharmacology, vol. 156, pp. 358-364, 2014.
47. M. Del Carmen Recio, R. M. Giner, S. Manez, and J. L. Rios, "Structural considerations on the iridoids as anti-inflammatory agents", Planta Medica, vol. 60, no. 3, pp. 232-234, 1994.
48. Z. L. Zhou, W. Yin, H. Zhang, Z. Feng, and J. Xia, "A new iridoid glycoside and potential MRB inhibitory activity of isolated compounds fromthe rhizomes of Cyperus rotundus L.", Natural Product Research, vol. 27, no. 19, pp. 1732-1736, 2013.
49. M. Seki, T. Tanaka, H. Matsuda et al., "Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model", British Journal of Ophthalmology, vol. 89, no. 4, pp. 504-507, 2005.
50. C. E. Plummer, E. O. MacKay, and K. N. Gelatt, "Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs", Veterinary Ophthalmology, vol. 9, no. 4, pp. 245-249, 2006.
51. C. Baudouin, "Allergic reaction to topical eyedrops", Current Opinion in Allergy and Clinical Immunology, vol. 5, no. 5, pp. 459-463, 2005.